Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1996 3
1998 2
2000 1
2001 1
2002 4
2003 4
2004 3
2005 5
2006 1
2007 3
2008 3
2009 1
2010 3
2011 5
2012 1
2013 2
2014 5
2015 6
2016 3
2017 2
2018 5
2019 3
2020 3
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Results by year
Filters applied: . Clear all
Page 1
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation.
Masucci GV, Cesano A, Hawtin R, Janetzki S, Zhang J, Kirsch I, Dobbin KK, Alvarez J, Robbins PB, Selvan SR, Streicher HZ, Butterfield LH, Thurin M. Masucci GV, et al. Among authors: dobbin kk. J Immunother Cancer. 2016 Nov 15;4:76. doi: 10.1186/s40425-016-0178-1. eCollection 2016. J Immunother Cancer. 2016. PMID: 27895917 Free PMC article. Review.
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.
Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash S, Shepherd FA, Ding K, Seymour L, Naoki K, Pennell N, Weir B, Verhaak R, Ladd-Acosta C, Golub T, Gruidl M, Sharma A, Szoke J, Zakowski M, Rusch V, Kris M, Viale A, Motoi N, Travis W, Conley B, Seshan VE, Meyerson M, Kuick R, Dobbin KK, Lively T, Jacobson JW, Beer DG. Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, et al. Among authors: dobbin kk. Nat Med. 2008 Aug;14(8):822-7. doi: 10.1038/nm.1790. Epub 2008 Jul 20. Nat Med. 2008. PMID: 18641660 Free PMC article.
Design of studies using DNA microarrays.
Simon R, Radmacher MD, Dobbin K. Simon R, et al. Among authors: dobbin k. Genet Epidemiol. 2002 Jun;23(1):21-36. doi: 10.1002/gepi.202. Genet Epidemiol. 2002. PMID: 12112246 Review.
Immune monitoring technology primer.
Dobbin KK. Dobbin KK. J Immunother Cancer. 2015 Oct 20;3:40. doi: 10.1186/s40425-015-0086-9. eCollection 2015. J Immunother Cancer. 2015. PMID: 26500774 Free PMC article.
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy.
Masucci GV, Cesano A, Eggermont A, Fox BA, Wang E, Marincola FM, Ciliberto G, Dobbin K, Puzanov I, Taube J, Wargo J, Butterfield LH, Villabona L, Thurin M, Postow MA, Sondel PM, Demaria S, Agarwala S, Ascierto PA. Masucci GV, et al. Among authors: dobbin k. J Transl Med. 2017 Nov 3;15(1):223. doi: 10.1186/s12967-017-1325-2. J Transl Med. 2017. PMID: 29100546 Free PMC article.
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations.
Dobbin KK, Cesano A, Alvarez J, Hawtin R, Janetzki S, Kirsch I, Masucci GV, Robbins PB, Selvan SR, Streicher HZ, Zhang J, Butterfield LH, Thurin M. Dobbin KK, et al. J Immunother Cancer. 2016 Nov 15;4:77. doi: 10.1186/s40425-016-0179-0. eCollection 2016. J Immunother Cancer. 2016. PMID: 27891226 Free PMC article. Review.
Practical aspects of planning, building, and interpreting tissue microarrays: the Cooperative Prostate Cancer Tissue Resource experience.
Kajdacsy-Balla A, Geynisman JM, Macias V, Setty S, Nanaji NM, Berman JJ, Dobbin K, Melamed J, Kong X, Bosland M, Orenstein J, Bayerl J, Becich MJ, Dhir R, Datta MW; Cooperative Prostate Cancer Tissue Resource. Kajdacsy-Balla A, et al. Among authors: dobbin k. J Mol Histol. 2007 May;38(2):113-21. doi: 10.1007/s10735-006-9054-5. Epub 2007 Feb 21. J Mol Histol. 2007. PMID: 17318343 Review.
70 results